Clinical Study
Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis
Table 1
Characteristics of patients*.
| Age (years) | 63.1 (10.5) | M:F | 6:14 | RA duration (years) | 14.7 (10.8) | Tender joint count | 18.4 (8.9) | Swollen joint count | 7.6 (5.3) | CRP (mg/L) | 25.5 (26.7) | Patients with erosions (%) | 12 (60) | Patients with RF (%) | 14 (70) | Pain (VAS, 0–100 mm) | 51.8 (22.0) | Patient overall severity (VAS, 0–100 mm) | 49.3 (21.6) | Fatigue(VAS, 0–100 mm) | 62.2 (23.5) | Health assessment questionnaire score | 1.894 (0.454) | Disease activity score (DAS28) | 5.7 (1.2) |
|
|
Mean and SD (standard deviation) unless indicated, RA: rheumatoid arthritis, CRP: C-reactive protein, VAS: visual analogue scale.
|